Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin

Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin

Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...

Full description

Saved in:
Bibliographic Details
Main Authors: Pintu Prajapati, Pooja Patel, Dhrumi Naik, Anzarul Haque, Shailesh Shah
Format: Article
Language:English
Published: SpringerOpen 2024-11-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Metformin hydrochloride
Teneligliptin hydrobromide hydrate
Pioglitazone hydrochloride
Analytical quality by design
Response surface modeling
Online Access:https://doi.org/10.1186/s43094-024-00746-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items